The DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index; none of the 20 sources its claims cite is checked for support yet.
CRISPR Interference-Based Platform for Multimodal Genetic Screens in Human iPSC-Derived Neurons
Open accessPublished version of a preprint
Abstract
CRISPR/Cas9-based functional genomics have transformed our ability to elucidate mammalian cell biology. However, most previous CRISPR-based screens were conducted in cancer cell lines rather than healthy, differentiated cells. Here, we describe a CRISPR interference (CRISPRi)-based platform for genetic screens in human neurons derived from induced pluripotent stem cells (iPSCs). We demonstrate robust and durable knockdown of endogenous genes in such neurons and present results from three complementary genetic screens. First, a survival-based screen revealed neuron-specific essential genes and genes that improved neuronal survival upon knockdown. Second, a screen with a single-cell transcriptomic readout uncovered several examples of genes whose knockdown had strikingly cell-type-specific consequences. Third, a longitudinal imaging screen detected distinct consequences of gene knockdown on neuronal morphology. Our results highlight the power of unbiased genetic screens in iPSC-derived differentiated cell types and provide a platform for systematic interrogation of normal and disease states of neurons. VIDEO ABSTRACT.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 20 cited sources checked · 0 supported · 0 flagged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We demonstrate robust and durable knockdown of endogenous genes in such neurons”
- Also stated in: § Robust CRISPR interference in human iPSC-derived neurons · boosted
“Our platform thus enables potent CRISPRi knockdown of endogenous genes in iPSC-derived neurons.”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Also stated in: § Robust CRISPR interference in human iPSC-derived neurons · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“or activity as evaluated by calcium imaging (Fig. S1F and Movies S1, S2).”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > RESULTS > Robust CRISPR interference in human iPSC-derived neurons
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found that expression of CRISPRi machinery and/or sgRNAs did not cause detectable DNA damage (Fig. S1C,D)”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > RESULTS > Robust CRISPR interference in human iPSC-derived neurons
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the vast majority of sgRNAs that altered survival in pooled screens also altered survival in our arrayed longitudinal survival analysis (Fig. 7D).”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > RESULTS > An arrayed CRISPRi platform for rich phenotyping by longitudinal imaging
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The vast majority of neuron-essential genes were detectable at the transcript level, further supporting the specificity of our screen results.”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > RESULTS > A pooled CRISPRi screen reveals neuron-essential genes
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we observed that two independent sgRNAs targeting PPP1R12C each caused continued proliferation instead of neuronal differentiation in a subset of iPSCs (Fig. S4F,G)”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > RESULTS > Inducible CRISPRi distinguishes neuronal differentiation and survival phenotypes
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“By clustering gene knockdown groups based on the signature of differential gene expression, we found transcriptomic signatures associated with knockdown of functionally related genes (Fig. 4C).”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > RESULTS > CROP-Seq generates mechanistic hypotheses for genes controlling neuronal survival
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“hierarchical clustering of individual sgRNAs based on these features led to coclustering of the two sgRNAs targeting a given gene for the majority of genes (Fig. 7E).”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > RESULTS > An arrayed CRISPRi platform for rich phenotyping by longitudinal imaging
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we identified a small number of genes, including PPCDC, UROD and MAT2A, for which knockdown was less toxic in the presence of astrocytes (Fig. 3F).”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > RESULTS > Pooled validation of hit genes
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We validated the strong neuronal dependence on the cholesterol biogenesis pathway pharmacologically using the HMG-CoA reductase inhibitor mevastatin (Fig. 2E)”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > RESULTS > A pooled CRISPRi screen reveals neuron-essential genes
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
- It may state two separate claims as one. 20
- Probably not a substantial claim. 20
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and did not affect neuronal differentiation (Fig. S1E)”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > RESULTS > Robust CRISPR interference in human iPSC-derived neurons
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This analysis revealed a shared core set of essential genes, as expected, and additional iPSC-specific and neuron-specific essential genes (Fig. 2D).”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > RESULTS > A pooled CRISPRi screen reveals neuron-essential genes
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“only a few genes, including SQLE, MMAB, MVK, UQCRQ, and ATP5B, showed high similarity (similarity score > 0.15) in the transcriptomic changes they induced in iPSCs versus neurons. Knockdown of most genes induced distinct transcriptomic responses in the two cell types.”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > RESULTS > CROP-Seq reveals neuron-specific transcriptomic consequences of gene knockdown
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“MAT2A is essential in neurons, but not iPSCs (Fig. 6B).”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > RESULTS > CROP-Seq reveals neuron-specific transcriptomic consequences of gene knockdown
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“sgRNAs targeting PPP1R12C were strongly enriched when TMP was added at the iPSC stage, but this phenotype was substantially weaker when TMP was added at the neuron stage.”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > RESULTS > Inducible CRISPRi distinguishes neuronal differentiation and survival phenotypes
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“MAP3K12 knockdown caused downregulation of a vast array of proteins involved in cytoskeletal organization, and upregulation of specific synaptotagmins”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > RESULTS > CROP-Seq generates mechanistic hypotheses for genes controlling neuronal survival
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Ribosomal genes and the anti-apoptotic transcription factor Brn3a (encoded by POU4F1) were upregulated.”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > RESULTS > CROP-Seq generates mechanistic hypotheses for genes controlling neuronal survival
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Knockdown phenotypes of hit genes were strongly correlated between neurons at different time points, but distinctly less correlated between neurons and iPSCs (Fig. 2C).”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > RESULTS > A pooled CRISPRi screen reveals neuron-essential genes
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In both iPSCs and neurons, all positive hits and most of the negative hits from the primary screen were confirmed in the validation screen (Fig. 3C).”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > RESULTS > Pooled validation of hit genes
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“or neurite growth (Fig. S6C).”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > RESULTS > An arrayed CRISPRi platform for rich phenotyping by longitudinal imaging
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found that neither CRISPRi machinery nor non-targeting sgRNAs affected neuronal survival (Fig. S6B)”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > RESULTS > An arrayed CRISPRi platform for rich phenotyping by longitudinal imaging
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“knockdown of the essential E1 ubiquitin activating enzyme, UBA1 (Fig. 5B)”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > RESULTS > CROP-Seq reveals neuron-specific transcriptomic consequences of gene knockdown
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Median number of genes detected per cell was around 5,000 for iPSCs and 4,600 for neurons.”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > STAR METHODS > QUANTIFICATION AND STATISTICAL ANALYSIS
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean reads per cell was around 84,000 for iPSCs and 91,000 for neurons.”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > STAR METHODS > QUANTIFICATION AND STATISTICAL ANALYSIS
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“which yields large quantities of highly homogeneous neurons, a prerequisite for robust population-based screens.”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > INTRODUCTION
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“induced expression of different transcription factors yield other types of neurons, such as motor neurons (Hester et al., 2011; Shi et al., 2018) and inhibitory neurons (Yang et al., 2017).”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > DISCUSSION
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Despite their usefulness, iPSC-derived neurons have limitations – in particular, they do not fully recapitulate all features of mature (or aging) neurons in the human brain.”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > DISCUSSION
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
In the paper
“Second, it is inducible and reversible (Gilbert et al., 2014)”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > DISCUSSION
What the sources say
- Not checked yetcites Gilbert et al., 2014 source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“our large-scale CRISPRi screen in human iPSC-derived neurons uncovered genes that control the survival of neurons, but not cancer cells or iPSCs”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > RESULTS > A pooled CRISPRi screen reveals neuron-essential genes
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neurons are a highly specialized and disease-relevant cell type, and thus it is crucial to study certain human gene functions in these cells.”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > DISCUSSION
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✗ Checkable: fails✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may be too vague to check against evidence. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In addition to the Ngn2-driven generation of glutamatergic neurons (Fernandopulle et al., 2018; Wang et al., 2017; Zhang et al., 2013) used here”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > DISCUSSION
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“CRISPRi-i3N iPSCs were transduced with the pool at 70% MOI (quantified as fraction of BFP-positive cells by flow cytometry) and were transduced cells selected by 1 ug/ml of puromycin to obtain a population of cells that was ~85% BFP-positive.”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > STAR METHODS > EXPERIMENTAL MODEL AND SUBJECT DETAILS
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“the library representation was ~35,000 cells / library element on Day 14 and ~28,000 cells / library element on Day 28.”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > STAR METHODS > EXPERIMENTAL MODEL AND SUBJECT DETAILS
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“For a given cell, sgRNA(s) whose UMI counts were greater than 4 standard deviations of the mean UMI counts of all sgRNAs were assigned to that cell as its identity.”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > STAR METHODS > QUANTIFICATION AND STATISTICAL ANALYSIS
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“approximately 2 million of these cells were harvested as Day 0 sample (corresponding to a library representation of ~9,000 cells/library element)”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > STAR METHODS > EXPERIMENTAL MODEL AND SUBJECT DETAILS
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Cells with only one assigned sgRNA were retained for further analysis.”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > STAR METHODS > QUANTIFICATION AND STATISTICAL ANALYSIS
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“a gene was discarded if it was targeted by two sgRNAs and the correlation of the two sgRNAs was less than 0.8.”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > STAR METHODS > QUANTIFICATION AND STATISTICAL ANALYSIS
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The initial MOI, quantified as the fraction of BFP-positive cells by flow cytometry, was ~15%, corresponding to a library representation of ~450 cells per library element.”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > STAR METHODS > EXPERIMENTAL MODEL AND SUBJECT DETAILS
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Day 14 neurons from each replicate of co-culture experiment were harvested, the library representation was ~50,000 neurons/library element.”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > STAR METHODS > EXPERIMENTAL MODEL AND SUBJECT DETAILS
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Approximately 2 million of Day 10 iPSCs from each replicate were harvested, corresponding to a library representation of ~9,000 cells/library element.”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > STAR METHODS > EXPERIMENTAL MODEL AND SUBJECT DETAILS
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“CRISPRi-i3 N iPSCs were infected with a pool of selected sgRNAs in the CROP-Seq vector pMK1334 at a low multiplicity of infection to minimize double infection.”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > STAR METHODS > EXPERIMENTAL MODEL AND SUBJECT DETAILS
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“192 sgRNAs, including 184 sgRNAs targeting 92 selected hit genes from the primary screen (two sgRNAs per gene) and 8 non-targeting control sgRNAs, were individually cloned into the secondary screening vector pMK1334 and verified by Sanger sequencing.”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > STAR METHODS > EXPERIMENTAL MODEL AND SUBJECT DETAILS
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“the estimated library representation for these time points was ~410 cells/library element on Day 14, ~380 cells/library element on Day 21, and ~330 cells/library element on Day 28.”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > STAR METHODS > EXPERIMENTAL MODEL AND SUBJECT DETAILS
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“For each target gene, the top 50% cells with best on-target knockdown were retained.”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > STAR METHODS > QUANTIFICATION AND STATISTICAL ANALYSIS
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Subsequently, knockdown phenotype scores for each sgRNA were calculated as LFCs of sgRNA counts between two samples and were normalized by subtracting the median of non-targeting control sgRNAs.”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > STAR METHODS > QUANTIFICATION AND STATISTICAL ANALYSIS
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“At the end of treatment, cells were assessed by flow cytometry (83% expressed high levels of BFP)”
§ CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons > STAR METHODS > EXPERIMENTAL MODEL AND SUBJECT DETAILS
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper relies on this without support.
The AAVS1 locus, where the inducible Ngn2 transgene was integrated, lies within the PPP1R12C gene.
“Interestingly, the AAVS1 locus, into which the inducible Ngn2 transgene was integrated, resides within the PPP1R12C gene.”
The paper relies on this without support.
Primary human neurons are difficult to obtain from human donors and cannot be expanded because they are post-mitotic.
“primary neurons are difficult to obtain from human donors, and non-expandable due to their post-mitotic nature.”
The paper relies on this without support.
Most previous CRISPR-based screens were conducted in cancer cell lines or stem cells rather than healthy differentiated human cells.
“Most previous CRISPR-based screens were implemented in cancer cell lines or stem cells rather than healthy differentiated human cells”
The paper relies on this without support.
CRISPRi reduces gene function by partial knockdown rather than complete knockout, allowing study of essential genes.
“Furthermore, CRISPRi perturbs gene function by partial knockdown, rather than knockout, thereby enabling the investigation of the biology of essential genes.”
The paper relies on this without support.
sgRNA abundance in pooled screens reflects cell survival or proliferation.
“Based on the depletion or enrichment of sgRNAs targeting specific genes at different time points compared to day 0, we identified hit genes for which knockdown was toxic or beneficial to either iPSCs or neurons at different time points (Fig. 2B, Fig. S2B).”
The paper relies on this without support.
iPSCs can be made from readily available cells, genetically engineered, expanded, and differentiated into various cell types.
“They can be made from readily available cells, such as skin fibroblasts or peripheral mononuclear blood cells; they can be genetically engineered and subsequently expanded to generate large numbers of isogenic cells; and they can then be differentiated into a variety of cell types”
The paper relies on this without support.
The presence of astrocytes in co-culture is representative of the brain environment.
“In the brain, many neuronal functions are supported by glial cells, particularly astrocytes.”
The paper relies on this without support.
CRISPR interference reduces gene expression partially rather than completely eliminating it.
“Third, it perturbs gene function via partial knockdown, as opposed to knockout”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This approach was pioneered in mammalian cells using RNA interference80,81, but CRISPR-based platforms have enabled the generation of substantially larger genetic interaction maps82, including CRISPRa-based gain-of-function maps83 and maps that combine gain- and loss-of-function perturbations to map directional pathways84.”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Doxycycline concentration differs by a factor of 1,000
MinorThe neuronal-plating procedures specify 2 μg/μL doxycycline in Cortical Neuron Culture Medium, whereas the formulation of that same medium specifies 2 μg/mL.
“resuspended in Cortical Neuron Culture Medium with doxycycline (2 ug/uL)”
“and optionally 2μg/mL doxycycline.”
Citations
Cites
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
CellProfiler: image analysis software for identifying and quantifying cell phenotypes
Carpenter, A. E., Jones, T. R., Lamprecht, M. R., Clarke, C., Kang, I. H., Friman, O., Guertin, D. A., Chang, J. H., Lindquist, R. A., Moffat, J., et al. (2006) · Genome biology · doi:10.1186/gb-2006-7-10-r100 · Cited by 5,212
Fast gene set enrichment analysisPreprint
Korotkevich, G., Sukhov, V., Budin, N., Shpak, B., Artyomov, M. N., & Sergushichev, A. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/060012 · Cited by 3,742
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696
Flagged first, then by citations
1 of the 68 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing
Nuñez, J. K., Chen, J., Pommier, G. C., Cogan, J. Z., Replogle, J. M., Adriaens, C., Ramadoss, G. N., Shi, Q., Hung, K. L., Samelson, A. J., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.025 · Cited by 760
Self-citationMitochondrial stress is relayed to the cytosol by an OMA1–DELE1–HRI pathway
Guo, X., Aviles, G., Liu, Y., Tian, R., Unger, B. A., Lin, Y.-H. T., Wiita, A. P., Xu, K., Correia, M. A., & Kampmann, M. (2020) · Nature · doi:10.1038/s41586-020-2078-2 · Cited by 674
Self-citationLRP1 is a master regulator of tau uptake and spread
Rauch, J. N., Luna, G., Guzman, E., Audouard, M., Challis, C., Sibih, Y. E., Leshuk, C., Hernandez, I., Wegmann, S., Hyman, B. T., et al. (2020) · Nature · doi:10.1038/s41586-020-2156-5 · Cited by 541
Self-citationTDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A
Brown, A., Wilkins, O. G., Keuss, M. J., Kargbo-Hill, S. E., Zanovello, M., Lee, W. C., Bampton, A., Lee, F. C. Y., Masino, L., Qi, Y. A., et al. (2022) · Nature · doi:10.1038/s41586-022-04436-3 · Cited by 545
Self-citationMolecular characterization of selectively vulnerable neurons in Alzheimer’s disease
Leng, K., Li, E., Eser, R., Piergies, A., Sit, R., Tan, M., Neff, N., Li, S. H., Rodriguez, R. D., Suemoto, C. K., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00764-7 · Cited by 485
Self-citationInduced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications
Cerneckis, J., Cai, H., & Shi, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01809-0 · Cited by 452
Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis
Tian, R., Abarientos, A., Hong, J., Hashemi, S. H., Yan, R., Dräger, N., Leng, K., Nalls, M. A., Singleton, A. B., Xu, K., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00862-0 · Cited by 414
Self-citationPredicting transcriptional outcomes of novel multigene perturbations with GEARS
Roohani, Y., Huang, K., & Leskovec, J. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-01905-6 · Cited by 355
A reference human induced pluripotent stem cell line for large-scale collaborative studies
Pantazis, C. B., Yang, A., Lara, E., McDonough, J. A., Blauwendraat, C., Peng, L., Oguro, H., Kanaujiya, J., Zou, J., Sebesta, D., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.11.004 · Cited by 310
Self-citationA new era in functional genomics screens
Przybyla, L., & Gilbert, L. A. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-021-00409-w · Cited by 281
Toxoplasma gondii infection and its implications within the central nervous system
Matta, S. K., Rinkenberger, N., Dunay, I. R., & Sibley, L. D. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00518-7 · Cited by 259
A CRISPRi/a platform in human iPSC-derived microglia uncovers regulators of disease states
Dräger, N. M., Sattler, S. M., Huang, C. T.-L., Teter, O. M., Leng, K., Hashemi, S. H., Hong, J., Aviles, G., Clelland, C. D., Zhan, L., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01131-4 · Cited by 258
Self-citationTruncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia
Prudencio, M., Humphrey, J., Pickles, S., Brown, A.-L., Hill, S. E., Kachergus, J. M., Shi, J., Heckman, M. G., Spiegel, M. R., Cook, C., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci139741 · Cited by 231
Self-citationGenomics, convergent neuroscience and progress in understanding autism spectrum disorder
Willsey, H. R., Willsey, A. J., Wang, B., & State, M. W. (2022) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00576-7 · Cited by 239
Neuronal enhancers are hotspots for DNA single-strand break repair
Wu, W., Kargbo-Hill, S. E., Nathan, W. J., Paiano, J., Callen, E., Wang, D., Shinoda, K., van Wietmarschen, N., Colón-Mercado, J. M., Zong, D., et al. (2021) · Nature · doi:10.1038/s41586-021-03468-5 · Cited by 223
Self-citationA cellular taxonomy of the adult human spinal cord
Yadav, A., Matson, K. J. E., Li, L., Hua, I., Petrescu, J., Kang, K., Alkaslasi, M. R., Lee, D. I., Hasan, S., Galuta, A., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.01.007 · Cited by 220
Self-citationHeterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity
Zhang, Y., Guo, L. E., Gonzales, P. K., Gendron, T. F., Wu, Y., Jansen‐West, K. R., O’Raw, A. D., Pickles, S. R., Prudencio, M., Carlomagno, Y., et al. (2019) · Science · doi:10.1126/science.aav2606 · Cited by 211
Self-citationCRISPR-Cas Tools and Their Application in Genetic Engineering of Human Stem Cells and Organoids
Hendriks, D. F. G., Clevers, H. C., & Artegiani, B. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.10.014 · Cited by 202
scPerturb: harmonized single-cell perturbation data
Peidli, S., Green, T. D., Shen, C., Gross, T., Min, J., Garda, S., Yuan, B., Schumacher, L. J., Taylor-King, J. P., Marks, D. S., et al. (2024) · Nature Methods · doi:10.1038/s41592-023-02144-y · Cited by 194
Autophagy Assays for Biological Discovery and Therapeutic Development
Mizushima, N., & Murphy, L. O. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.07.006 · Cited by 197
Mis-spliced transcripts generate de novo proteins in TDP-43–related ALS/FTD
Seddighi, S., Qi, Y. A., Brown, A., Wilkins, O. G., Bereda, C., Belair, C., Zhang, Y., Prudencio, M., Keuss, M. J., Khandeshi, A. J., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adg7162 · Cited by 200
Self-citationWang, M., Li, A., Sekiya, M., Beckmann, N. D., Quan, X., Schrode, N., Fernando, M. B., Yu, A., Zhu, L., Cao, J., et al. (2021) · Neuron · doi:10.1016/j.neuron.2020.11.002 · Cited by 185
Chen, J. J., Nathaniel, D. L., Raghavan, P., Nelson, M., Tian, R., Tse, E., Hong, J. Y., See, S. K., Mok, S.-A., Hein, M. Y., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009432 · Cited by 170
Self-citationTitrating gene expression using libraries of systematically attenuated CRISPR guide RNAs
Jost, M., Santos, D. A., Saunders, R. A., Horlbeck, M. A., Hawkins, J. S., Scaria, S. M., Norman, T. M., Hussmann, J. A., Liem, C. R., Gross, C. A., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0387-5 · Cited by 164
CRISPR-based functional genomics for neurological disease
Kampmann, M. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0373-z · Cited by 163
Self-citationGPNMB confers risk for Parkinson’s disease through interaction with α-synuclein
Diaz-Ortiz, M. E., Seo, Y., Posavi, M., Carceles Cordon, M., Clark, E., Jain, N., Charan, R., Gallagher, M. D., Unger, T. L., Amari, N., et al. (2022) · Science · doi:10.1126/science.abk0637 · Cited by 158
Leng, K., Rose, I. V. L., Kim, H., Xia, W., Romero‐Fernandez, W., Rooney, B., Koontz, M., Li, E., Ao, Y., Wang, S., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01180-9 · Cited by 158
Self-citationMaximizing CRISPRi efficacy and accessibility with dual-sgRNA libraries and optimal effectors
Replogle, J. M., Bonnar, J. L., Pogson, A. N., Liem, C. R., Maier, N. K., Ding, Y., Russell, B. J., Wang, X., Leng, K., Guna, A., et al. (2022) · eLife · doi:10.7554/elife.81856 · Cited by 158
Self-citationMaking neurons, made easy: The use of Neurogenin-2 in neuronal differentiation
Hulme, A. E., Maksour, S., Clair‐Glover, M. S., Miellet, S., & Dottori, M. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.11.015 · Cited by 153
Neurons require glucose uptake and glycolysis in vivo
Li, H., Guglielmetti, C., Sei, Y. J., Zilberter, M. Y., Page, L. M. L., Shields, L. Y., Yang, J. L., Nguyen, K., Tiret, B., Gao, X. Z., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112335 · Cited by 143
Self-citationBinan, L., Jiang, A., Danquah, S. A., Valakh, V., Simonton, B., Bezney, J., Manguso, R. T., Yates, K. B., Nehme, R., Cleary, B., et al. (2025) · Cell · doi:10.1016/j.cell.2025.02.012 · Cited by 142
Fernandes, H. J. R., Patikas, N., Foskolou, S., Field, S. F., Park, J.-E., Byrne, M. L., Bassett, A. R., & Metzakopian, E. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108263 · Cited by 141
Molecular and cellular mechanisms of selective vulnerability in neurodegenerative diseases
Kampmann, M. (2024) · Nature reviews. Neuroscience · doi:10.1038/s41583-024-00806-0 · Cited by 142
Self-citationEmerging trends in organ-on-a-chip systems for drug screening
Wang, Y., Gao, Y., Pan, Y., Zhou, D., Liu, Y., Yin, Y. B., Yang, J., Wang, Y., & Song, Y. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.02.006 · Cited by 132
CRISPR/Cas-Based Epigenome Editing: Advances, Applications, and Clinical Utility
Goell, J., & Hilton, I. B. (2021) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.10.012 · Cited by 125
Functional regulatory variants implicate distinct transcriptional networks in dementia
Cooper, Y. A., Teyssier, N., Dräger, N. M., Guo, Q., Davis, J. E., Sattler, S. M., Yang, Z., Patel, A. M., Wu, S. J., Kosuri, S., et al. (2022) · Science · doi:10.1126/science.abi8654 · Cited by 121
Self-citationA comprehensive resource for induced pluripotent stem cells from patients with primary tauopathies
Karch, C. M., Kao, A. W., Karydas, A., Onanuga, K., Martinez, R., Argouarch, A., Wang, C., Huang, C., Sohn, P. D., Bowles, K. R., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.09.006 · Cited by 119
Self-citationWells, M. F., Nemesh, J., Ghosh, S., Mitchell, J. M., Salick, M. R., Mello, C. J., Meyer, D., Pietilainen, O., Piccioni, F., Guss, E. J., et al. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.01.010 · Cited by 116
Active DNA demethylation promotes cell fate specification and the DNA damage response
Wang, D., Wu, W., Callen, E., Pavani, R., Zolnerowich, N., Kodali, S., Zong, D., Wong, N., Noriega, S., Nathan, W. J., et al. (2022) · Science · doi:10.1126/science.add9838 · Cited by 113
Self-citationBassil, R., Shields, K., Granger, K., Zein, I., Ng, S., & Chih, B. (2021) · Nature Communications · doi:10.1038/s41467-021-25344-6 · Cited by 106
Organ‐On‐A‐Chip Models of the Blood–Brain Barrier: Recent Advances and Future Prospects
Kawakita, S., Mandal, K., Mou, L., Mecwan, M. M., Zhu, Y., Li, S., Sharma, S., Hernández, A. L., Nguyen, H. T., Maity, S., et al. (2022) · Small · doi:10.1002/smll.202201401 · Cited by 103
Giacomelli, E., Vahsen, B. F., Calder, E. L., Xu, Y., Scaber, J., Gray, E., Dafinca, R., Talbot, K., & Studer, L. (2022) · Cell stem cell · doi:10.1016/j.stem.2021.12.008 · Cited by 100
Association of a common genetic variant with Parkinson’s disease is mediated by microglia
Langston, R. G., Beilina, A., Reed, X., Kaganovich, A., Singleton, A. B., Blauwendraat, C., Gibbs, J. R., & Cookson, M. R. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abp8869 · Cited by 93
Base editing screens map mutations affecting interferon-γ signaling in cancer
Coelho, M. A., Cooper, S., Strauß, M. E., Karakoç, E., Bhosle, S. G., Gonçalves, E., Picco, G., Burgold, T., Cattaneo, C. M., Veninga, V., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2022.12.009 · Cited by 94
Oltion, K., Carelli, J. D., Yang, T., See, S. K., Wang, H., Kampmann, M., & Taunton, J. (2023) · Cell · doi:10.1016/j.cell.2022.12.025 · Cited by 90
Self-citationDe Pace, R., Britt, D. J., Mercurio, J., Foster, A. M., Djavaherian, L., Hoffmann, V., Abebe, D., & Bonifacino, J. S. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107775 · Cited by 87
Lalli, M. A., Avey, D. R., Dougherty, J. D., Milbrandt, J., & Mitra, R. D. (2020) · Genome Research · doi:10.1101/gr.262295.120 · Cited by 89
Li, Y., Dou, X., Liu, J., Xiao, Y., Zhang, Z., Hayes, L. R., Wu, R., Fu, X., Ye, Y., Yang, B., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01374-9 · Cited by 85
Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS/FTD
Hayes, L. R., & Kaláb, P. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01260-5 · Cited by 86
Human iPSC 4R tauopathy model uncovers modifiers of tau propagation
Parra Bravo, C., Giani, A. M., Madero-Perez, J., Zhao, Z., Wan, Y., Samelson, A. J., Wong, M. Y., Evangelisti, A., Cordes, E., Fan, L., et al. (2024) · Cell · doi:10.1016/j.cell.2024.03.015 · Cited by 90
Self-citationImage-based pooled whole-genome CRISPRi screening for subcellular phenotypes
Kanfer, G., Sarraf, S. A., Maman, Y., Baldwin, H. A., Domínguez‐Martín, E., Johnson, K. R., Ward, M. E., Kampmann, M., Lippincott‐Schwartz, J., & Youle, R. J. (2020) · The Journal of Cell Biology · doi:10.1083/jcb.202006180 · Cited by 83
Self-citationBRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2
Samelson, A. J., Tran, Q. D., Robinot, R., Carrau, L., Rezelj, V. V., Kain, A. M., Chen, M., Ramadoss, G. N., Guo, X., Lim, S. A., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-021-00821-8 · Cited by 76
Self-citationA functional genetic toolbox for human tissue-derived organoids
Sun, D., Evans, L., Perrone, F., Sokleva, V., Lim, K., Rezakhani, S., Lutolf, M., Zilbauer, M., & Rawlins, E. L. (2021) · eLife · doi:10.7554/elife.67886 · Cited by 71
Black, J. B., McCutcheon, S. R., Dube, S., Barrera, A., Klann, T. S., Rice, G., Adkar, S. S., Soderling, S. H., Reddy, T. E., & Gersbach, C. A. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108460 · Cited by 71
De Novo VPS4A Mutations Cause Multisystem Disease with Abnormal Neurodevelopment
Rodger, C. E., Flex, E., Allison, R. J., Sanchis‐Juan, A., Hasenahuer, M. A., Cecchetti, S., French, C. E., Edgar, J. R., Carpentieri, G., Ciolfi, A., et al. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.10.012 · Cited by 69
Genome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies
McTague, A., Rossignoli, G., Ferrini, A., Barral, S., & Kurian, M. A. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.630600 · Cited by 67
TDP-43 loss induces cryptic polyadenylation in ALS/FTD
Bryce-Smith, S., Brown, A., Chien, M. Z. Y. J., Dattilo, D., Mehta, P. R., Mattedi, F., Barattucci, S., Mikheenko, A., Zanovello, M., Pellegrini, F., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02050-w · Cited by 72
CRISPR screens in iPSC-derived neurons reveal principles of tau proteostasis
Samelson, A. J., Ariqat, N., McKetney, J., Rohanitazangi, G., Bravo, C., Bose, R., Travaglini, K. J., Lam, V. L., Goodness, D., Ta, T., et al. (2026) · Cell · doi:10.1016/j.cell.2025.12.038 · Cited by 65
Self-citationA Presynaptic Perspective on Transport and Assembly Mechanisms for Synapse Formation
Rizalar, F. S., Roosen, D. A., & Haucke, V. (2020) · Neuron · doi:10.1016/j.neuron.2020.09.038 · Cited by 67
Soutar, M. P. M., Melandri, D., O’Callaghan, B., Annuario, E., Monaghan, A. E., Welsh, N. J., D’Sa, K., Guelfi, S., Zhang, D., Pittman, A. M., et al. (2022) · Brain · doi:10.1093/brain/awac325 · Cited by 63
Developing nociceptor-selective treatments for acute and chronic pain
Jayakar, S. S., Shim, J., Jo, S., Bean, B. P., Singeç, I., & Woolf, C. J. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abj9837 · Cited by 62
The frontier of live tissue imaging across space and time
Huang, Q., Garrett, A., Bose, S., Blocker, S. J., Rios, A. C., Clevers, H. C., & Shen, X. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.02.010 · Cited by 60
Viñas Torné, R., Wiatrak, M., Piran, Z., Fan, S., Jiang, L., Teichmann, S. A., Nitzan, M., & Brbić, M. (2026) · Nature Biotechnology · doi:10.1038/s41587-025-02777-8 · Cited by 58
Lai, J. D., Berlind, J. E., Fricklas, G., Lie, C., Urenda, J., Lam, K., Maria, N. S. S., Jacobs, R. E., Yu, V. L., Zhao, Z., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.03.004 · Cited by 58
Gowrishankar, S., Lyons, L., Rafiq, N. M., Roczniak-Ferguson, A., De Camilli, P., & Ferguson, S. M. (2021) · Molecular Biology of the Cell · doi:10.1091/mbc.e20-06-0382 · Cited by 62
Dual inhibition of TMPRSS2 and Cathepsin B prevents SARS-CoV-2 infection in iPS cells
Hashimoto, R., Sakamoto, A., Deguchi, S., Yi, R., Sano, E., Hotta, A., Takahashi, K., Yamanaka, S., & Takayama, K. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.10.016 · Cited by 56
Gaucher disease provides a unique window into Parkinson disease pathogenesis
Hertz, E., Chen, Y., & Sidransky, E. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00999-z · Cited by 62
Single-cell mapping of lipid metabolites using an infrared probe in human-derived model systems
Bai, Y., Camargo, C. M., Glasauer, S. M. K., Gifford, R., Tian, X., Longhini, A. P., & Kosik, K. S. (2024) · Nature Communications · doi:10.1038/s41467-023-44675-0 · Cited by 57
CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma
Ramkumar, P., Abarientos, A., Tian, R., Seyler, M., Leong, J. T., Chen, M., Choudhry, P., Hechler, T., Shah, N. D., Wong, S. W. K., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019001346 · Cited by 55
Self-citationMoving from in vitro to in vivo CRISPR screens
Kuhn, M., Santinha, A. J., & Platt, R. J. (2021) · Gene and Genome Editing · doi:10.1016/j.ggedit.2021.100008 · Cited by 56
A fully automated FAIMS-DIA mass spectrometry-based proteomic pipeline
Reilly, L., Lara, E., Ramos, D. M., Li, Z., Pantazis, C. B., Stadler, J., Santiana, M., Roberts, J. L., Faghri, F., Hao, Y., et al. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100593 · Cited by 52
Self-citationMassively parallel techniques for cataloguing the regulome of the human brain
Townsley, K. G., Brennand, K., & Huckins, L. M. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-00740-1 · Cited by 52
Neurodegeneration cell per cell
Balusu, S., Praschberger, R., Lauwers, E., Strooper, B. D., & Verstreken, P. (2023) · Neuron · doi:10.1016/j.neuron.2023.01.016 · Cited by 53
Sen, T., & Thummer, R. P. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00564-w · Cited by 52
Zhang, Z., Wang, X., Park, S. S., Song, H., & Ming, G. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.12.015 · Cited by 49
Strategies to Promote Long-Distance Optic Nerve Regeneration
Yang, S.-G., Li, C.-P., Peng, X.-Q., Teng, Z., Liu, C.-M., & Zhou, F. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00119 · Cited by 49
NudC guides client transfer between the Hsp40/70 and Hsp90 chaperone systems
Biebl, M. M., Delhommel, F., Faust, O., Żak, K. M., Agam, G. N., Guo, X., Mühlhofer, M., Dahiya, V., Hillebrand, D., Popowicz, G. M., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2021.12.031 · Cited by 50
Self-citationModeling Psychiatric Disorder Biology with Stem Cells
Das, D., Feuer, K. L., Wahbeh, M. H., & Avramopoulos, D. (2020) · Current Psychiatry Reports · doi:10.1007/s11920-020-01148-1 · Cited by 49
FMRP regulates MFF translation to locally direct mitochondrial fission in neurons
Fenton, A. R., Peng, R., Bond, C., Hugelier, S., Lakadamyali, M., Chang, Y., Holzbaur, E. L. F., & Jongens, T. A. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01544-2 · Cited by 49
Modeling the complex genetic architectures of brain disease
Fernando, M. B., Ahfeldt, T., & Brennand, K. (2020) · Nature Genetics · doi:10.1038/s41588-020-0596-3 · Cited by 48
Genome-wide CRISPR/Cas9-knockout in human induced Pluripotent Stem Cell (iPSC)-derived macrophages
Navarro‐Guerrero, E., Tay, C., Whalley, J. P., Cowley, S. A., Davies, B., Knight, J. C., & Ebner, D. V. (2021) · Scientific Reports · doi:10.1038/s41598-021-82137-z · Cited by 48
High-resolution characterization of gene function using single-cell CRISPR tiling screen
Yang, L., Chan, A. K. N., Miyashita, K., Delaney, C. D., Wang, X., Li, H., Pokharel, S. P., Li, S., Li, M., Xu, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24324-0 · Cited by 45
Moysés‐Oliveira, M., Yadav, R., Erdin, S., & Talkowski, M. E. (2020) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2020.07.001 · Cited by 46
Creation of de novo cryptic splicing for ALS and FTD precision medicine
Wilkins, O. G., Chien, M. Z. Y. J., Wlaschin, J. J., Barattucci, S., Harley, P., Mattedi, F., Mehta, P. R., Pisliakova, M., Ryadnov, E. M., Keuss, M. J., et al. (2024) · Science · doi:10.1126/science.adk2539 · Cited by 46
Lee, S., McAfee, J. C., Lee, J., Gomez, A., Ledford, A. T., Clarke, D., Min, H., Gerstein, M., Boyle, A. P., Sullivan, P. F., et al. (2025) · Cell · doi:10.1016/j.cell.2024.12.022 · Cited by 45
Exploiting CRISPR Cas9 in Three-Dimensional Stem Cell Cultures to Model Disease
Gopal, S., Rodrigues, A. L., & Dordick, J. S. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00692 · Cited by 46
CRISPR-based functional genomics screening in human-pluripotent-stem-cell-derived cell types
Li, K., Ouyang, M., Zhan, J., & Tian, R. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100300 · Cited by 45
Self-citationLoss of TDP-43 induces synaptic dysfunction that is rescued by UNC13A splice-switching ASOsPreprint
Keuss, M. J., Harley, P., Ryadnov, E. M., Jackson, R. E., Zanovello, M., Wilkins, O. G., Barattucci, S., Mehta, P. R., Oliveira, M. G., Parkes, J. E., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.20.599684 · Cited by 46
Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis
Tian, R., Abarientos, A., Hong, J., Hashemi, S. H., Yan, R., Dräger, N., Leng, K., Nalls, M. A., Singleton, A. B., Xu, K., et al. (2020) · doi:10.1101/2020.06.27.175679 · Cited by 414
Self-citationFerguson, R., Goold, R., Coupland, L. A., Flower, M. D., & Tabrizi, S. J. (2024) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2024.04.015 · Cited by 43
Mulvey, B., Lagunas, T., & Dougherty, J. D. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.06.011 · Cited by 41
Massively Parallel CRISPR‐Based Genetic Perturbation Screening at Single‐Cell Resolution
Cheng, J., Lin, G., Wang, T., Wang, Y., Guo, W., Liao, J., Yang, P., Chen, J., Shao, X., Lu, X., et al. (2022) · Advanced Science · doi:10.1002/advs.202204484 · Cited by 42
SOX9 maintains human foetal lung tip progenitor state by enhancing WNT and RTK signalling
Sun, D., Llora Batlle, O., van den Ameele, J., Thomas, J. C., He, P., Lim, K., Tang, W., Xu, C., Meyer, K. B., Teichmann, S. A., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2022111338 · Cited by 38
Teter, O. M., McQuade, A., Hagan, V., Liang, W., Dräger, N. M., Sattler, S. M., Holmes, B. B., Castillo, V. C., Papakis, V., Leng, K., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02997-z · Cited by 38
Self-citationAscl1 and Ngn2 convert mouse embryonic stem cells to neurons via functionally distinct paths
Vainorius, G., Novatchkova, M., Michlits, G., Baar, J. C., Raupach, C., Lee, J., Yelagandula, R., Wernig, M., & Elling, U. (2023) · Nature Communications · doi:10.1038/s41467-023-40803-y · Cited by 39
Zhou, X., Lee, Y.-K., Li, X., Kim, H., Sánchez-Priego, C., Han, X., Tan, H., Zhou, S., Fu, Y., Purtell, K., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47440-z · Cited by 38
Functional Characterisation of a GWAS Risk Locus Identifies GPX3 as a Lead Candidate Gene in ALS
Restuadi, R., Steyn, F. J., Kabashi, E., Ngo, S. T., Cheng, F., Nabais, M. F., Thompson, M. J., Qi, T., Wu, Y., Henders, A. K., et al. (2020) · Genome Medicine · doi:10.1186/s13073-021-01006-6 · Cited by 39
Mitochondrial YME1L1 governs unoccupied protein translocase channels
Hsu, M.-C., Kinefuchi, H., Lei, L., Kikuchi, R., Yamano, K., & Youle, R. J. (2025) · Nature Cell Biology · doi:10.1038/s41556-024-01571-z · Cited by 38
Application of CRISPR genetic screens to investigate neurological diseases
So, R. W. L., Chung, S., Lau, H. H. C., Watts, J. J., Gaudette, E. V., Al‐Azzawi, Z. A. M., Bishay, J., Lin, L. T., Joung, J., Wang, X., et al. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0343-3 · Cited by 37
Local production of reactive oxygen species drives vincristine-induced axon degeneration
Gómez-Deza, J., Slavutsky, A. L., Nebiyou, M., & Pichon, C. E. L. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06227-8 · Cited by 35
Metadata
- Authors
- Tian, R., Gachechiladze, M. A., Ludwig, C. H., Laurie, M. T., Hong, J. Y., Nathaniel, D., Prabhu, A. V., Fernandopulle, M. S., Patel, R., Abshari, M., Ward, M. E., & Kampmann, M.
- Affiliations
- University of California, San Francisco (US)
- National Institutes of Health (US)
- Corresponding author
- Ward, Michael E.
- Kampmann, Martin
- ORCID
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2019-10
- Volume
- 104
- Issue
- 2
- Pages
- 239-255.e12
- ISSN
- 0896-6273 (ISSN-L)
- PMC
- PMC6813890
- OpenAlex
- W2967789674
- Cited by
- 543
- References
- 68
- Citations by year
- 2026: 85 · 2025: 116 · 2024: 103 · 2023: 60 · 2022: 66 · 2021: 62 · 2020: 45 · 2019: 6
- FWCI
- 15.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Neuron (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of General Medical Sciences
- Paul G. Allen Family Foundation
- National Institute of Neurological Disorders and Stroke
- National Institute on Aging
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- CRISPR interference, iPSC-derived neurons, functional genetic screens, gene knockdown, neuronal survival, essential genes, single-cell transcriptomics, neuronal morphology
- MeSH terms
- RNA-Seq, Cell Survival, Humans, Neurons, Microscopy, Confocal, Gene Knockdown Techniques, Induced Pluripotent Stem Cells, Single-Cell Analysis, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
